<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02441218</url>
  </required_header>
  <id_info>
    <org_study_id>CL3-16257-063</org_study_id>
    <secondary_id>2006-000708-18</secondary_id>
    <nct_id>NCT02441218</nct_id>
  </id_info>
  <brief_title>Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study</brief_title>
  <acronym>SHIFT</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Servier</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Servier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to demonstrate the superiority of ivabradine over
      placebo in the reduction of cardiovascular mortality or hospitalisation for worsening heart
      failure in patients with moderate to severe symptoms of chronic heart failure, a reduced left
      ventricular ejection fraction and currently receiving recommended therapy for this disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Composite Endpoint: First Event Among Cardiovascular Death (Including Death of Unknown Cause) or Hospitalization for Worsening Heart Failure.</measure>
    <time_frame>All over the study (up to 42 months).</time_frame>
    <description>Number of patients having experienced the Primary Composite Endpoint.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Death</measure>
    <time_frame>From the date of randomization until the date of death, up to 42 months</time_frame>
    <description>Component of the primary composite endpoint</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalisation for Worsening Heart Failure</measure>
    <time_frame>From the date of randomization to the date of first documented hospitalisation, up to 42 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause Mortality</measure>
    <time_frame>From the date of randomisation to death, up to 42 months.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death From Heart Failure</measure>
    <time_frame>From the date of randomisation to death, up to 42 months.</time_frame>
    <description>Component of cardiovascular death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalisation for Any Cause</measure>
    <time_frame>From the date of randomisation to the date of first documented hospitalisation, up to 42 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalisation for Cardiovascular Reason</measure>
    <time_frame>From the date of randomisation to the first documented hospitalisation, up to 42 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned Hospitalisation for Any Cause</measure>
    <time_frame>From the date of randomisation to the first documented hospitalisation, up to 42 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned Hospitalisation for CV Reason</measure>
    <time_frame>From the date of randomisation to the first documented hospitalisation, up to 42 months.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Composite Endpoint</measure>
    <time_frame>From the date of randomisation to the date of the first event, up to 42 months</time_frame>
    <description>CV death, hospitalisation for worsening HF or hospitalisation for non-fatal myocardial infarction</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">6505</enrollment>
  <condition>Chronic Heart Failure</condition>
  <arm_group>
    <arm_group_label>Ivabradine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ivabradine</intervention_name>
    <description>2.5mg, 5mg or 7.5mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
    <arm_group_label>Ivabradine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic Chronic heart failure (NYHA II, III or IV)

          -  Left ventricular systolic dysfunction (LVEF ≤ 35%)

          -  Sinus rhythm and resting heart rate ≥ 70 bpm

          -  Optimal and unchanged CHF medications or dosages

        Exclusion Criteria:

          -  Unstable condition within previous 4 weeks

          -  Myocardial infarction or coronary revascularisation within previous 2 months

          -  Stroke or transient cerebral ischaemia within previous 4 weeks

          -  Congenital heart disease

          -  Severe valvular disease

          -  Active myocarditis

          -  Permanent atrial fibrillation or flutter
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hôpital Pitié-Salpétrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Göteborg University</name>
      <address>
        <city>Göteborg</city>
        <zip>S 41685</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Sweden</country>
  </location_countries>
  <link>
    <url>http://clinicaltrials.servier.com/wp-content/uploads/CL3-16257-063_synopsis_report.pdf</url>
    <description>Results summary</description>
  </link>
  <results_reference>
    <citation>Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Erratum in: Lancet. 2010 Dec 11;376(9757):1988. Lajnscak, M [corrected to Lainscak, M]; Rabanedo, I Roldan [corrected to Rabadán, I Roldan]; Leva, M [corrected to Ieva, M].</citation>
    <PMID>20801500</PMID>
  </results_reference>
  <results_reference>
    <citation>Böhm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet. 2010 Sep 11;376(9744):886-94. doi: 10.1016/S0140-6736(10)61259-7.</citation>
    <PMID>20801495</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 5, 2015</study_first_submitted>
  <study_first_submitted_qc>May 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2015</study_first_posted>
  <results_first_submitted>May 12, 2015</results_first_submitted>
  <results_first_submitted_qc>June 22, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 29, 2015</results_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Researchers can ask for a study protocol, patient-level and/or study-level clinical trial data including clinical study reports (CSRs).
They can ask all interventional clinical studies:
submitted for new medicines and new indications approved after 1 January 2014 in the European Economic Area (EEA) or the United States (US).
Where Servier or an affiliate are the Marketing Authorization Holders (MAH). The date of the first Marketing Authorization of the new medicine (or the new indication) in one of the EEA Member States will be considered within this scope.</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The target population was adult patients with stable, moderate to severe chronic heart failure (CHF) and left ventricular systolic dysfunction, with optimal and unchanged CHF medications and dosages for ≥ 4 weeks.</recruitment_details>
      <pre_assignment_details>Following a run-in period of two weeks during which no study treatment was dispensed, the participants were randomised to receive ivabradine or placebo in addition to their usual cardiovascular treatment in double-blind treatment period.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Ivabradine</title>
          <description>Ivabradine: 2.5mg, 5mg or 7.5mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Placebo: Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3241"/>
                <participants group_id="P2" count="3264"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2663"/>
                <participants group_id="P2" count="2652"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="578"/>
                <participants group_id="P2" count="612"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="503"/>
                <participants group_id="P2" count="553"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="73"/>
                <participants group_id="P2" count="58"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ivabradine</title>
          <description>Ivabradine: 2.5mg, 5mg or 7.5mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Placebo: Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3241"/>
            <count group_id="B2" value="3264"/>
            <count group_id="B3" value="6505"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.7" spread="11.2"/>
                    <measurement group_id="B2" value="60.1" spread="11.5"/>
                    <measurement group_id="B3" value="60.4" spread="11.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="779"/>
                    <measurement group_id="B2" value="756"/>
                    <measurement group_id="B3" value="1535"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2462"/>
                    <measurement group_id="B2" value="2508"/>
                    <measurement group_id="B3" value="4970"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Beta-blocker intake at randomization</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2897"/>
                    <measurement group_id="B2" value="2923"/>
                    <measurement group_id="B3" value="5820"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="344"/>
                    <measurement group_id="B2" value="341"/>
                    <measurement group_id="B3" value="685"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Primary Composite Endpoint: First Event Among Cardiovascular Death (Including Death of Unknown Cause) or Hospitalization for Worsening Heart Failure.</title>
        <description>Number of patients having experienced the Primary Composite Endpoint.</description>
        <time_frame>All over the study (up to 42 months).</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Ivabradine: 2.5mg, 5mg or 7.5mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Composite Endpoint: First Event Among Cardiovascular Death (Including Death of Unknown Cause) or Hospitalization for Worsening Heart Failure.</title>
          <description>Number of patients having experienced the Primary Composite Endpoint.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3241"/>
                <count group_id="O2" value="3264"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="793"/>
                    <measurement group_id="O2" value="937"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.82</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.75</ci_lower_limit>
            <ci_upper_limit>0.90</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake at randomisation as a covariate.
P-value: Wald test</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiovascular Death</title>
        <description>Component of the primary composite endpoint</description>
        <time_frame>From the date of randomization until the date of death, up to 42 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Ivabradine: 2.5mg, 5mg or 7.5mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiovascular Death</title>
          <description>Component of the primary composite endpoint</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3241"/>
                <count group_id="O2" value="3264"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="449"/>
                    <measurement group_id="O2" value="491"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.128</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.91</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.80</ci_lower_limit>
            <ci_upper_limit>1.03</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake at randomisation as a covariate.
P-value: Wald test</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospitalisation for Worsening Heart Failure</title>
        <time_frame>From the date of randomization to the date of first documented hospitalisation, up to 42 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Ivabradine: 2.5mg, 5mg or 7.5mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Hospitalisation for Worsening Heart Failure</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3241"/>
                <count group_id="O2" value="3264"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="514"/>
                    <measurement group_id="O2" value="672"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.0001</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.74</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.66</ci_lower_limit>
            <ci_upper_limit>0.83</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake at randomisation as a covariate.
P-value: Wald test</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All-cause Mortality</title>
        <time_frame>From the date of randomisation to death, up to 42 months.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Ivabradine: 2.5mg, 5mg or 7.5mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
        </group_list>
        <measure>
          <title>All-cause Mortality</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3241"/>
                <count group_id="O2" value="3264"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="503"/>
                    <measurement group_id="O2" value="552"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.092</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.90</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.80</ci_lower_limit>
            <ci_upper_limit>1.02</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake at randomisation as a covariate.
P-value: Wald test</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Death From Heart Failure</title>
        <description>Component of cardiovascular death</description>
        <time_frame>From the date of randomisation to death, up to 42 months.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Ivabradine: 2.5mg, 5mg or 7.5mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Death From Heart Failure</title>
          <description>Component of cardiovascular death</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3241"/>
                <count group_id="O2" value="3264"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="113"/>
                    <measurement group_id="O2" value="151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0140</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.74</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.58</ci_lower_limit>
            <ci_upper_limit>0.94</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake at randomisation as a covariate.
P-value: Wald test</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospitalisation for Any Cause</title>
        <time_frame>From the date of randomisation to the date of first documented hospitalisation, up to 42 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Ivabradine: 2.5mg, 5mg or 7.5mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Hospitalisation for Any Cause</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3241"/>
                <count group_id="O2" value="3264"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1231"/>
                    <measurement group_id="O2" value="1356"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0027</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.89</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.82</ci_lower_limit>
            <ci_upper_limit>0.96</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake at randomisation as a covariate.
P-value: Wald test</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospitalisation for Cardiovascular Reason</title>
        <time_frame>From the date of randomisation to the first documented hospitalisation, up to 42 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Ivabradine: 2.5mg, 5mg or 7.5mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Hospitalisation for Cardiovascular Reason</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3241"/>
                <count group_id="O2" value="3264"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="977"/>
                    <measurement group_id="O2" value="1122"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0002</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.85</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.78</ci_lower_limit>
            <ci_upper_limit>0.92</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake at randomisation as a covariate.
P-value: Wald test</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Unplanned Hospitalisation for Any Cause</title>
        <time_frame>From the date of randomisation to the first documented hospitalisation, up to 42 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Ivabradine: 2.5mg, 5mg or 7.5mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Unplanned Hospitalisation for Any Cause</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3241"/>
                <count group_id="O2" value="3264"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1137"/>
                    <measurement group_id="O2" value="1264"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0013</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.88</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.81</ci_lower_limit>
            <ci_upper_limit>0.95</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake at randomisation as a covariate.
P-value: Wald test</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Unplanned Hospitalisation for CV Reason</title>
        <time_frame>From the date of randomisation to the first documented hospitalisation, up to 42 months.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Ivabradine: 2.5mg, 5mg or 7.5mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Unplanned Hospitalisation for CV Reason</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3241"/>
                <count group_id="O2" value="3264"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="909"/>
                    <measurement group_id="O2" value="1047"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0002</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.84</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.77</ci_lower_limit>
            <ci_upper_limit>0.92</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake at randomisation as a covariate.
P-value: Wald test</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Secondary Composite Endpoint</title>
        <description>CV death, hospitalisation for worsening HF or hospitalisation for non-fatal myocardial infarction</description>
        <time_frame>From the date of randomisation to the date of the first event, up to 42 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ivabradine</title>
            <description>Ivabradine: 2.5mg, 5mg or 7.5mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Secondary Composite Endpoint</title>
          <description>CV death, hospitalisation for worsening HF or hospitalisation for non-fatal myocardial infarction</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3241"/>
                <count group_id="O2" value="3264"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="825"/>
                    <measurement group_id="O2" value="979"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.0001</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.82</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.74</ci_lower_limit>
            <ci_upper_limit>0.89</ci_upper_limit>
            <estimate_desc>Estimate of the hazard ratio between treatment groups based on an adjusted Cox proportional hazards model with beta-blocker intake at randomisation as a covariate. P-value: Wald test</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From randomisation to death, up to 42 months</time_frame>
      <desc>The Randomised Set consisted of 6505 patients (3241 patients in the ivabradine group and 3264 patients in the placebo group). The Safety Set consisted of 6492 patients: 13 randomised patients were excluded from the Safety Set because they did not take any study drug (9 patients in the ivabradine group and 4 patients in the placebo group).</desc>
      <group_list>
        <group group_id="E1">
          <title>Ivabradine</title>
          <description>Ivabradine: 2.5mg, 5mg or 7.5mg tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Placebo: Matching placebo tablets to be taken orally twice daily, at 12-hours intervals, in the morning and in the evening during meals up to 42 months.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 7.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1369" subjects_at_risk="3232"/>
                <counts group_id="E2" subjects_affected="1481" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3232"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hypochromic anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy mediastinal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Nephrogenic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Spleen disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" events="11" subjects_affected="9" subjects_at_risk="3232"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="65" subjects_affected="62" subjects_at_risk="3232"/>
                <counts group_id="E2" events="61" subjects_affected="54" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Adams-Stokes syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="61" subjects_affected="51" subjects_at_risk="3232"/>
                <counts group_id="E2" events="60" subjects_affected="55" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="140" subjects_affected="113" subjects_at_risk="3232"/>
                <counts group_id="E2" events="139" subjects_affected="119" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="139" subjects_affected="126" subjects_at_risk="3232"/>
                <counts group_id="E2" events="114" subjects_affected="106" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="22" subjects_affected="22" subjects_at_risk="3232"/>
                <counts group_id="E2" events="20" subjects_affected="19" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Atrial thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Atrioventricular block third degree</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiac aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="766" subjects_affected="506" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1093" subjects_affected="665" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" events="13" subjects_affected="12" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="21" subjects_affected="17" subjects_at_risk="3232"/>
                <counts group_id="E2" events="21" subjects_affected="19" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory distress</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="3232"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Conduction disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cor pulmonale</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Coronary artery insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Intracardiac thrombus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Mitral valve stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="63" subjects_affected="57" subjects_at_risk="3232"/>
                <counts group_id="E2" events="51" subjects_affected="51" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Nodal arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Rhythm idioventricular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Sick sinus syndrome</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Sinoatrial block</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Supraventricular extrasystoles</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Torsade de pointes</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Tricuspid valve incompetence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ventricular dysfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="3232"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" events="21" subjects_affected="20" subjects_at_risk="3232"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ventricular tachyarrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="34" subjects_affected="31" subjects_at_risk="3232"/>
                <counts group_id="E2" events="52" subjects_affected="46" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal angiodysplasia haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Acute vestibular syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism primary</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="11" subjects_affected="9" subjects_at_risk="3232"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cataract cortical</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Iridocyclitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lens dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Open angle glaucoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Presbyopia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Retinal artery embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Retinopathy proliferative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ulcerative keratitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Uveitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Anal fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Colonic haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Colonic polyp</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Disbacteriosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diverticulum duodenal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Erosive duodenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Erosive oesophagitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Femoral hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastric disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastric polyps</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastric ulcer perforation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastritis atrophic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastritis haemorrhagic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastroduodenal ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastroduodenitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastrointestinal erosion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastrointestinal perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="3232"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Inguinal hernia, obstructive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Mechanical ileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Megacolon</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Mesenteric artery thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pancreatic cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pancreatitis chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pancreatitis necrotising</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Polyp colorectal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Reflux oesophagitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Sigmoiditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Thrombosis mesenteric vessel</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Accidental death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiac death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hyperthermia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Implant site inflammation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Implant site ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" events="73" subjects_affected="73" subjects_at_risk="3232"/>
                <counts group_id="E2" events="68" subjects_affected="68" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" events="111" subjects_affected="111" subjects_at_risk="3232"/>
                <counts group_id="E2" events="119" subjects_affected="119" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Biliary dilatation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3232"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cytolytic hepatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hepatic congestion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hepatitis cholestatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hepatitis toxic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hepatorenal failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Post cholecystectomy syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cryoglobulinaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Abdominal wall abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Abscess oral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ascites infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bronchitis acute</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="3232"/>
                <counts group_id="E2" events="20" subjects_affected="18" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bronchitis acute viral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="3232"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bursitis infective</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Candida sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Clostridium colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diabetic foot infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diabetic gangrene</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Epidemic nephropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Epstein-Barr virus infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastroenteritis enteroviral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastrointestinal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Graft infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hepatitis B</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hepatitis C</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection viral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lung abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lung infection pseudomonal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Malaria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Necrotising fasciitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Obstructive chronic bronchitis with acute exacerbation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Oropharyngeal candidiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Otitis media chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Perianal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Peritoneal tuberculosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="79" subjects_affected="70" subjects_at_risk="3232"/>
                <counts group_id="E2" events="69" subjects_affected="65" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pneumonia klebsiella</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pneumonia primary atypical</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Post procedural cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Postoperative infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pulmonary tuberculosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Purulent synovitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pyelonephritis chronic</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pyonephrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3232"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Salmonellosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker malfunction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage traumatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Chest injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Closed head injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Coronary artery restenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diaphragmatic injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Foreign body in eye</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator malfunction</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Intervertebral disc injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Multiple drug overdose accidental</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Operative haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pacemaker complication</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Polytraumatism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Postoperative hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Renal injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Scrotal haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Skeletal injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Stent occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Therapeutic agent toxicity</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Tracheostomy malfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Traumatic brain injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Urinary bladder rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Vascular graft occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Wound evisceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Anticoagulation drug level above therapeutic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Arteriogram</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Arteriogram coronary</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="3232"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Blood chloride decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Carcinoembryonic antigen increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiac electrophysiologic study</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker evaluation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiovascular evaluation</sub_title>
                <counts group_id="E1" events="32" subjects_affected="27" subjects_at_risk="3232"/>
                <counts group_id="E2" events="31" subjects_affected="27" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Catheterisation cardiac</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Coagulation time prolonged</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Colonoscopy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Electrocardiogram abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hysteroscopy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Investigation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Nephrological examination</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pregnancy test positive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Sleep study</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Transplant evaluation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ultrasound Doppler</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="25" subjects_affected="23" subjects_at_risk="3232"/>
                <counts group_id="E2" events="34" subjects_affected="33" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus non-insulin-dependent</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" events="8" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Metabolic syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Dactylitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Monarthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Osteitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Osteoporotic fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Systemic sclerosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Tenosynovitis stenosans</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Benign biliary neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Benign breast neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Benign lung neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bladder papilloma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Breast cancer in situ</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Breast cancer stage IV</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cervix carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Chronic myeloid leukaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Clear cell carcinoma of the kidney</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diffuse large B-cell lymphoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gallbladder cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hepatic cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage III</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lung carcinoma cell type unspecified stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Malignant mediastinal neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Nasopharyngeal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Oropharyngeal cancer stage unspecified</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Papillary thyroid cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Prostate cancer recurrent</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Prostatic adenoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Rectal adenoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Rectal cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Renal cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma stage unspecified</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Salivary gland neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Small intestine carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Thyroid adenoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Tongue carcinoma stage IV</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm malignant stage unspecified</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Brain stem haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Carotid artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cerebellar haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cerebellar infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cerebral arteriosclerosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cerebral artery embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cerebral haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="3232"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="3232"/>
                <counts group_id="E2" events="17" subjects_affected="16" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cerebrovascular disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Dementia Alzheimer's type</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Encephalitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Extrapyramidal disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Facial palsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Grand mal convulsion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hypertensive encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic coma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hypoxic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Intracranial haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ischaemic cerebral infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="37" subjects_affected="34" subjects_at_risk="3232"/>
                <counts group_id="E2" events="48" subjects_affected="46" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Migraine with aura</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Spinal cord haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="3232"/>
                <counts group_id="E2" events="21" subjects_affected="20" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Syncope vasovagal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Tarsal tunnel syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="3232"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Vascular dementia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Vascular encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar insufficiency</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Pregnancy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Affective disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Aggression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Alcoholism</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Anxiety disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Disturbance in social behaviour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Schizophreniform disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute prerenal failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Anuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Calculus ureteric</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diabetic nephropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Glomerulonephritis chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Nephropathy toxic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Nephrotic syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Polyuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="3232"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="3232"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Stress incontinence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Phimosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Postmenopausal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Uterine haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" events="25" subjects_affected="20" subjects_at_risk="3232"/>
                <counts group_id="E2" events="31" subjects_affected="25" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Alveolitis allergic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="12" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Asthmatic crisis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bronchial hyperactivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bronchopneumopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="53" subjects_affected="35" subjects_at_risk="3232"/>
                <counts group_id="E2" events="50" subjects_affected="33" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Chronic respiratory failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diaphragmatic hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Dyspnoea at rest</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Dyspnoea exacerbated</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Haemopneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hydrothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Nasal cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Non-cardiogenic pulmonary oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="3232"/>
                <counts group_id="E2" events="24" subjects_affected="23" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pulmonary infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Status asthmaticus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Cutaneous lupus erythematosus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Dermatitis atopic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Dry gangrene</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Subcutaneous emphysema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Social stay hospitalisation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Alcohol detoxification</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Arrhythmia prophylaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Arterial bypass operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiac ablation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiac aneurysm repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker insertion</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiac rehabilitation therapy</sub_title>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="3232"/>
                <counts group_id="E2" events="10" subjects_affected="7" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiac resynchronisation therapy</sub_title>
                <counts group_id="E1" events="21" subjects_affected="20" subjects_at_risk="3232"/>
                <counts group_id="E2" events="30" subjects_affected="29" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Carotid endarterectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cataract operation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cholecystectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Coronary angioplasty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Coronary arterial stent insertion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Coronary artery surgery</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Coronary revascularisation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus management</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ear operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Eventration procedure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Gastric banding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Heart transplant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator insertion</sub_title>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="3232"/>
                <counts group_id="E2" events="21" subjects_affected="21" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator replacement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Incisional hernia repair</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Inguinal hernia repair</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Knee operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Mitral valve replacement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Obesity surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Percutaneous coronary intervention</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Physiotherapy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Rehabilitation therapy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Renal tumour excision</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Tooth extraction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Transurethral prostatectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ureteral stent removal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Weight loss diet</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Arterial thrombosis limb</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis obliterans</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bleeding varicose vein</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Blood pressure inadequately controlled</sub_title>
                <counts group_id="E1" events="19" subjects_affected="17" subjects_at_risk="3232"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diabetic macroangiopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diabetic vascular disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Extremity necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Femoral artery aneurysm</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Femoral artery dissection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Femoral artery occlusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Iliac artery embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Iliac artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Iliac artery thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="3232"/>
                <counts group_id="E2" events="18" subjects_affected="15" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Subclavian artery stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis superficial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="3232"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Venous thrombosis limb</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="3232"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_vocab>MedDRA 7.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2694" subjects_at_risk="3232"/>
                <counts group_id="E2" subjects_affected="2577" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="93" subjects_affected="91" subjects_at_risk="3232"/>
                <counts group_id="E2" events="96" subjects_affected="92" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="97" subjects_affected="85" subjects_at_risk="3232"/>
                <counts group_id="E2" events="109" subjects_affected="93" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="176" subjects_affected="161" subjects_at_risk="3232"/>
                <counts group_id="E2" events="138" subjects_affected="123" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" events="38" subjects_affected="35" subjects_at_risk="3232"/>
                <counts group_id="E2" events="42" subjects_affected="36" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="142" subjects_affected="134" subjects_at_risk="3232"/>
                <counts group_id="E2" events="30" subjects_affected="26" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="337" subjects_affected="289" subjects_at_risk="3232"/>
                <counts group_id="E2" events="369" subjects_affected="299" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" events="45" subjects_affected="40" subjects_at_risk="3232"/>
                <counts group_id="E2" events="115" subjects_affected="102" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Supraventricular extrasystoles</sub_title>
                <counts group_id="E1" events="41" subjects_affected="39" subjects_at_risk="3232"/>
                <counts group_id="E2" events="50" subjects_affected="49" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" events="140" subjects_affected="129" subjects_at_risk="3232"/>
                <counts group_id="E2" events="137" subjects_affected="131" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="37" subjects_affected="34" subjects_at_risk="3232"/>
                <counts group_id="E2" events="28" subjects_affected="26" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Phosphenes</sub_title>
                <counts group_id="E1" events="95" subjects_affected="89" subjects_at_risk="3232"/>
                <counts group_id="E2" events="18" subjects_affected="16" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="34" subjects_affected="34" subjects_at_risk="3232"/>
                <counts group_id="E2" events="36" subjects_affected="36" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="44" subjects_affected="38" subjects_at_risk="3232"/>
                <counts group_id="E2" events="40" subjects_affected="34" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Bronchitis acute</sub_title>
                <counts group_id="E1" events="64" subjects_affected="59" subjects_at_risk="3232"/>
                <counts group_id="E2" events="79" subjects_affected="68" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="74" subjects_affected="66" subjects_at_risk="3232"/>
                <counts group_id="E2" events="76" subjects_affected="68" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="70" subjects_affected="66" subjects_at_risk="3232"/>
                <counts group_id="E2" events="85" subjects_affected="70" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="60" subjects_affected="56" subjects_at_risk="3232"/>
                <counts group_id="E2" events="78" subjects_affected="69" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="40" subjects_affected="39" subjects_at_risk="3232"/>
                <counts group_id="E2" events="28" subjects_affected="25" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" events="33" subjects_affected="30" subjects_at_risk="3232"/>
                <counts group_id="E2" events="36" subjects_affected="34" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="35" subjects_affected="33" subjects_at_risk="3232"/>
                <counts group_id="E2" events="55" subjects_affected="52" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="3232"/>
                <counts group_id="E2" events="40" subjects_affected="37" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="40" subjects_affected="36" subjects_at_risk="3232"/>
                <counts group_id="E2" events="47" subjects_affected="42" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" events="58" subjects_affected="55" subjects_at_risk="3232"/>
                <counts group_id="E2" events="49" subjects_affected="47" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" events="193" subjects_affected="178" subjects_at_risk="3232"/>
                <counts group_id="E2" events="46" subjects_affected="45" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" events="48" subjects_affected="46" subjects_at_risk="3232"/>
                <counts group_id="E2" events="42" subjects_affected="42" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="32" subjects_affected="32" subjects_at_risk="3232"/>
                <counts group_id="E2" events="35" subjects_affected="35" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="125" subjects_affected="116" subjects_at_risk="3232"/>
                <counts group_id="E2" events="125" subjects_affected="115" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hypercholesterolaemia</sub_title>
                <counts group_id="E1" events="33" subjects_affected="33" subjects_at_risk="3232"/>
                <counts group_id="E2" events="34" subjects_affected="34" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="29" subjects_affected="27" subjects_at_risk="3232"/>
                <counts group_id="E2" events="56" subjects_affected="53" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hyperuricaemia</sub_title>
                <counts group_id="E1" events="47" subjects_affected="47" subjects_at_risk="3232"/>
                <counts group_id="E2" events="52" subjects_affected="52" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="3232"/>
                <counts group_id="E2" events="42" subjects_affected="40" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="62" subjects_affected="55" subjects_at_risk="3232"/>
                <counts group_id="E2" events="50" subjects_affected="45" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="45" subjects_affected="43" subjects_at_risk="3232"/>
                <counts group_id="E2" events="67" subjects_affected="58" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="53" subjects_affected="50" subjects_at_risk="3232"/>
                <counts group_id="E2" events="71" subjects_affected="69" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" events="28" subjects_affected="27" subjects_at_risk="3232"/>
                <counts group_id="E2" events="45" subjects_affected="45" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="42" subjects_affected="37" subjects_at_risk="3232"/>
                <counts group_id="E2" events="68" subjects_affected="55" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="44" subjects_affected="42" subjects_at_risk="3232"/>
                <counts group_id="E2" events="44" subjects_affected="44" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Blood pressure inadequately controlled</sub_title>
                <counts group_id="E1" events="259" subjects_affected="216" subjects_at_risk="3232"/>
                <counts group_id="E2" events="215" subjects_affected="188" subjects_at_risk="3260"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="62" subjects_affected="59" subjects_at_risk="3232"/>
                <counts group_id="E2" events="91" subjects_affected="82" subjects_at_risk="3260"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review publication and/or communication related to the study results and can require changes. In case of a patent application, the sponsor can delay its authorization for publication or communication of the study results until the date of international registration of the patent.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The section Other Adverse Events (Not including serious) has been completed by the sponsor to include only the Non Serious Adverse Events emergent on treatment during the study.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Therapeutic Innovation Pole</name_or_title>
      <organization>Institut de Recherches Internationales Servier (I.R.I.S.)</organization>
      <phone>+33155724366</phone>
      <email>clinicaltrials@servier.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

